Paratek Pharmaceuticals
PRTK
#9013
Rank
NZ$0.22 B
Marketcap
NZ$3.85
Share price
0.00%
Change (1 day)
12.60%
Change (1 year)

Earnings for Paratek Pharmaceuticals (PRTK)

Earnings in 2023 (TTM): -NZ$72.95 Million

According to Paratek Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.16 Billion. In 2022 the company made an earning of -NZ$78.27 Million a decrease over its 2021 earnings that were of -NZ$70.83 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Paratek Pharmaceuticals from 2004 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -NZ$72.95 Million-6.8%
2022 -NZ$78.27 Million10.5%
2021 -NZ$70.83 Million-46.16%
2020 -NZ$0.14 Billion-31.93%
2019 -NZ$0.2 Billion11.12%
2018 -NZ$0.18 Billion21.19%
2017 -NZ$0.15 Billion-23.22%
2016 -NZ$0.19 Billion54.68%
2015 -NZ$0.13 Billion309.5%
2014 -NZ$29.52 Million-29.88%
2013 -NZ$42.09 Million
2011 -NZ$6.5 Million-59.18%
2010 -NZ$15.91 Million-53.53%
2009 -NZ$34.23 Million-161.93%
2008 NZ$55.25 M-187.43%
2007 -NZ$63.2 Million11.93%
2006 -NZ$56.47 Million31.69%
2005 -NZ$42.88 Million32.4%
2004 -NZ$32.39 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Spectrum Pharmaceuticals
SPPI
-NZ$0.11 Billion 41.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$35.62 M-147.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-NZ$0.9 Billion 1,086.69%๐Ÿ‡บ๐Ÿ‡ธ USA